Related references
Note: Only part of the references are listed.Current Approaches and Challenges for Monitoring Treatment Response in Colon and Rectal Cancer
Elizabeth McKeown et al.
JOURNAL OF CANCER (2014)
Evaluation of Methylation of MGMT (O6-Methylguanine-DNA Methyltransferase) Gene Promoter in Sporadic Colorectal Cancer
Mohammadreza Farzanehfar et al.
DNA AND CELL BIOLOGY (2013)
CD133 expression in colorectal adenomas
Adriana Handra-Luca et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
Different patterns of DNA methylation of the two distinct O6-methylguanine-DNA methyltransferase (O6-MGMT) promoter regions in colorectal cancer
P. Mokarram et al.
MOLECULAR BIOLOGY REPORTS (2013)
Kras Gene Mutation and RASSF1A, FHIT and MGMT Gene Promoter Hypermethylation: Indicators of Tumor Staging and Metastasis in Adenocarcinomatous Sporadic Colorectal Cancer in Indian Population
Rupal Sinha et al.
PLOS ONE (2013)
PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
Christophe Rosty et al.
PLOS ONE (2013)
Discovery of the cancer stem cell related determinants of radioresistance
Claudia Peitzsch et al.
RADIOTHERAPY AND ONCOLOGY (2013)
CD133: A cancer stem cells marker, is used in colorectal cancers
Fei Ren et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Colon cancer stem cells: Controversies and perspectives
Maria Ausiliatrice Puglisi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer
Yifan Peng et al.
WORLD JOURNAL OF SURGERY (2013)
Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis
Pierluigi Pilati et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer
Shu-Wen Jao et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker
Meike Schneider et al.
BMC CANCER (2012)
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients
Claudio Coco et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Consolacion Melguizo et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Increased expression of CD133 is a strong predictor of poor outcome in stage I colorectal cancer patients
Luca Reggiani Bonetti et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Prognostic Impact of CD133 mRNA Expression in 48 Glioblastoma Patients Treated with Concomitant Radiochemotherapy: A Prospective Patient Cohort at a Single Institution
Philippe Metellus et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers
Kaori Shima et al.
CANCER CAUSES & CONTROL (2011)
Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells
Ke-li Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Cancer stem cell hypotheses: Impact on modern molecular physiology and pharmacology research
Igor Pantic
JOURNAL OF BIOSCIENCES (2011)
Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma
Hong-Qing Xi et al.
JOURNAL OF CLINICAL PATHOLOGY (2011)
Inconsistent Immunohistochemical Expression Patterns of Four Different CD133 Antibody Clones in Glioblastoma
Simon K. Hermansen et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence
Kyung-Hwa Lee et al.
LANGENBECKS ARCHIVES OF SURGERY (2011)
Upregulated CD133 expression in tumorigenesis of colon cancer cells
Zhi-Li Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis
C. Maenhaut et al.
CARCINOGENESIS (2010)
MGMT-535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy
Jee Hyun Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas
Vasiliki Psofaki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
Chun-Yan Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
MGMT methylation is associated primarily with the germline C > T SNP (rs16906252) in colorectal cancer and normal colonic mucosa
Nicholas J. Hawkins et al.
MODERN PATHOLOGY (2009)
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Eric Van Cutsem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma
Dongho Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
CD133 expression is an independent prognostic marker for low survival in colorectal cancer
D. Horst et al.
BRITISH JOURNAL OF CANCER (2008)
Immunohistochemical detection of CD133 expression in colorectal cancer: A clinicopathological study
Motohiro Kojima et al.
CANCER SCIENCE (2008)
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma
Yutaka Suehiro et al.
CLINICAL CANCER RESEARCH (2008)
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
Terje Ahlquist et al.
MOLECULAR CANCER (2008)
MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer
Shuji Ogino et al.
CARCINOGENESIS (2007)
MGMT hypermethylation: A prognostic foe, a predictive friend
Filipe V. Jacinto et al.
DNA REPAIR (2007)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines
MJ Duffy et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
